High Dose Nimodipine Treatment Adjunct - 1
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000332 |
Recruitment Status :
Completed
First Posted : September 21, 1999
Last Update Posted : February 24, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cocaine-Related Disorders | Drug: Nimodipine | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 0 participants |
Primary Purpose: | Treatment |
Official Title: | High Dose Nimodipine Pharmacotherapy Adjunct |
Actual Study Start Date : | May 1998 |
Actual Primary Completion Date : | January 2000 |
Actual Study Completion Date : | April 2000 |

- Stimulated and non-stimulated craving
- Stimulated and non-stimulated withdrawal
- Anxiety, depression
- Heart rate

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 22 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000332
United States, District of Columbia | |
Washington DC VA | |
Washington, District of Columbia, United States, 20422 |
Principal Investigator: | Steven Deutsch, M.D. | Washington D.C. Veterans Affairs Medical Center |
ClinicalTrials.gov Identifier: | NCT00000332 |
Other Study ID Numbers: |
NIDA-3-0009-1 Y01-3-0009-1 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | February 24, 2017 |
Last Verified: | December 2002 |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Cocaine-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Nimodipine Antihypertensive Agents |
Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Vasodilator Agents |